More on NKTX

- Summary
- Chart
- Profile
- Historical

Data

- Earnings
- Ratings (7.9 Score)

Upcoming Events

- Earnings (11/11/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Nkarta (NQ:NKTX)
Delayed: 1.79 +0.05 (2.87%)
Prev. Close $1.74  
Open$1.74 
52 Wk High$ 
52 Wk Low$ 
Day High$1.81 
Day Low$1.66 
P/E N/A  
EPS$ 
Volume959,153 

Friends, Peers and Foes (?): FATE, GTBP, IBRX, IOVA, CMPX (more...)

Sep 28, 2026 07:31 AM Nkarta (NKTX) Reiterated at Buy by Stifel Amid Ongoing Ntrust Trials
Sep 10, 2026 07:00 AM Nkarta to Participate in September Investor Conferences
Sep 8, 2026 07:00 AM Nkarta to Present Initial Autoimmune Clinical Data for NKX019 at American College of Rheumatology (ACR) Convergence 2026
Aug 14, 2026 08:10 AM Nkarta Inc. (NKTX) PT Lowered to $10 at Stifel as Ntrust-1/2 Trial Enrollment Progresses
Aug 11, 2026 06:51 AM Nkarta Inc. (NKTX) PT Lowered to $14 at H.C. Wainwright
Aug 10, 2026 06:18 PM Nkarta, Inc. (NKTX) Misses Q2 EPS by 18c
Aug 10, 2026 04:24 PM Nkarta Reports Second Quarter 2026 Financial Results and Corporate Highlights
Aug 10, 2026 04:20 PM Form 10-Q Nkarta, Inc. For: Jun 30
Aug 10, 2026 04:13 PM Form 8-K Nkarta, Inc. For: Aug 10
Jul 23, 2026 01:30 AM Cyllene Therapeutics Expands Leadership Team to Support Corporate Growth and Clinical Product Development
View All Articles

Entities mentioned with NKTX

View All Entities